RxDoctor Payments Data

David Shaffer

Medical Oncology · Albany, NYNPI 1487625158

Payments from drug & device makers

$3,177,447in general payments, 2019–2025

Across 1,481 payments — averaging $2145.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Genentech, Inc.$650K
  • Janssen Research & Development, LLC$562K
  • E.r. Squibb & Sons, L.L.C.$489K
  • Eli Lilly$453K
  • Incyte Corporation$303K
  • Merck$228K
  • plus $492K from 7 others
$2,990in research payments, 2019–2025

Across 2 payments — averaging $1495.20 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • F. Hoffmann-la Roche AG$3K

What the payments were for

  • Education$15100%

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Genentech, Inc.64$650,465
Janssen Research & Development, LLC726$562,281
E.r. Squibb & Sons, L.L.C.21$489,269
Eli Lilly13$452,517
Incyte Corporation326$302,841
Merck26$227,739
Pfizer60$216,963
Eisai Inc.209$192,792
AstraZeneca10$42,928
Seagen Inc.13$12,431
Novartis2$10,458
Mirati Therapeutics, Inc.5$8,851
Clovis Oncology, Inc.6$7,910

How this compares

$3,177,447 in reported general payments places this provider in the 80th percentile of 498 medical oncology providers in New York.

See all medical oncology providers in New York

Other medical oncology in Albany

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →